MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Home・Listă Acțiuni・VolitionRX Ltd

VolitionRX Ltd

Închisă

0.43 -2.27

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

0.43

Maxim

0.45

Indicatori cheie
By Trading Economics
Venit	-837K -6.3M
Vânzări	160K 407K
Marjă de profit	-1,552.559
Angajați	70
EBITDA	-475K -5.5M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+233.33% upside

Dividende
By Dow Jones
Următoarele câștiguri	13 nov. 2025

Statistici piață
By TradingEconomics
Capitalizare de piață	-16M 50M
Deschiderea anterioară	2.7
Închiderea anterioară	0.43

VolitionRX Ltd Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 oct. 2025, 18:13 UTC

Principalele dinamici ale pieței

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 oct. 2025, 17:05 UTC

Principalele dinamici ale pieței

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 oct. 2025, 15:03 UTC

Principalele dinamici ale pieței

Obook Shares Sink Following Public Debut

17 oct. 2025, 14:41 UTC

Principalele dinamici ale pieței

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 oct. 2025, 23:25 UTC

Achiziții, Fuziuni, Preluări

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 oct. 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 oct. 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 oct. 2025, 21:07 UTC

Market Talk

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 oct. 2025, 21:07 UTC

Market Talk

Global Equities Roundup: Market Talk

17 oct. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 oct. 2025, 20:34 UTC

Market Talk

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 oct. 2025, 20:27 UTC

Market Talk

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 oct. 2025, 19:46 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 oct. 2025, 19:45 UTC

Market Talk

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 oct. 2025, 18:45 UTC

Market Talk

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 oct. 2025, 17:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 oct. 2025, 17:51 UTC

Market Talk

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 oct. 2025, 17:44 UTC

Market Talk

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 oct. 2025, 17:35 UTC

Market Talk

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 oct. 2025, 16:20 UTC

Market Talk

Câștiguri

Tech, Media & Telecom Roundup: Market Talk

17 oct. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 oct. 2025, 16:14 UTC

Market Talk

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 oct. 2025, 16:04 UTC

Market Talk

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 oct. 2025, 15:58 UTC

Market Talk

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 oct. 2025, 15:56 UTC

Câștiguri

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 oct. 2025, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17 oct. 2025, 15:43 UTC

Market Talk

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 oct. 2025, 14:58 UTC

Market Talk

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 oct. 2025, 14:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 oct. 2025, 14:35 UTC

Market Talk

Câștiguri

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Comparație

Modificare preț

VolitionRX Ltd Așteptări

Obiectiv de preț

By TipRanks

233.33% sus

Prognoză pe 12 luni

Medie 1.5 USD 233.33%

Maxim 2.5 USD

Minim 0.5 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVolitionRX Ltd - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 3 analiști care au acordat evaluări ale acțiunilor VolitionRX Ltd - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.